1,494 8% EBITDA Bio-Based Product Business4/ 113 179 59 -48% -67% 259 238 -8% EBITDA Resource Business5/ 59 133 93 58% -30% 81 226 181% EBITDA Others 6/ (25) (25) (12) 54% 53% (25) (37) -48% Profit
: Pursuant to 11 August 2 Company’s the Compa The Compa net profit of profit margi in the cons million baht profit ratio o The remark last year an from the fir jumped in recovered t a foundatio The details
% Profit (loss) before loss from allowance 149,195 (514,097) 129% 129,365 145,783 -11% margin 7% -21% 8% 9% Profit / (Loss) before interest and taxation (221,748) (2,202,353) 90% (500,440) (1,134,625) 56
services (excluding fuel cost) 2,058.80 1,554.21 504.59 32.5 Revenue from finance lease contract 750.86 885.23 (134.37) (15.2) Share of profit of associates and joint ventures 1,081.13 888.83 192.30 21.6
วันที่ 15 ตุลาคม 2545 1 NO. (SUTHA-SET) 016/2019/EN 14 August 2019 Subject : Clarification of Q2/2019 the total revenues and the Net profit change more than 20% To : The President of the Stock
significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 2 of the year 2020, the company had cost of sale of 98.72 million bath compare to 93.54 million baht last year with the increasing of
continuously make profit to the shareholders. The Company is currently expanding the business into personal loan which is still in the first three years of operation and it must take time to increase the size of
expenses 1,557.6 1,199.2 1,901.2 358.4 29.9 (343.6) (18.1) Profit for the period 121.6 166.2 136.9 (44.6) (26.8) (15.3) (11.2) In Q2-2022, The Thai Economy improved from the previous quarter and the number
Company's ordinary shareholders resulting in a decrease in share of profit or voting rights in CAZ decreased from 51.30% to 36.64% or equivalent to not more than 28.57%. However, CAZ will still be the